The use of a wild-type dihydrofolate reductase-encoding cDNA as a dominant selectable marker and induction of expression by methotrexate
- 16 November 1992
- Vol. 121 (2) , 365-369
- https://doi.org/10.1016/0378-1119(92)90145-f
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- High level expression of human proteins in murine hybridoma cells: induction by methotrexate in the absence of gene amplificationBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1991
- High-level expression of chimeric antibodies using adapted cDNA variable region cassettesJournal of Immunological Methods, 1989
- High-level expression of c-H-ras1 fails to fully transform rat-1 cells.Molecular and Cellular Biology, 1988
- Transient inhibition of DNA synthesis results in increased dihydrofolate reductase synthesis and subsequent increased DNA content per cell.Molecular and Cellular Biology, 1986
- Stable reduction of thymidine kinase activity in cells expressing high levels of anti-sense RNACell, 1985
- Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogeneNature, 1984
- A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain geneCell, 1983
- Construction and use of a dominant, selectable marker: a Harvey sarcoma virus-dihydrofolate reductase chimera.Molecular and Cellular Biology, 1983
- Assay of urokinase activity in plasma with a chromogenic substrateThrombosis Research, 1981
- Transcriptional regulation of hemoglobin switching in chicken embryos.Molecular and Cellular Biology, 1981